YTL Communications deploys ADVA timing solution in LTE-A network
26.11.2019 11:00:00 EET | Business Wire | Press release
ADVA (FSE: ADV) today announced that YTL Communications has deployed its Oscilloquartz synchronization technology to support the nationwide rollout of LTE-Advanced services. The OSA 5410 and OSA 5420 Series create an end-to-end timing solution that delivers the highly precise phase and frequency synchronization needed for next-generation mobile and broadband connectivity. ADVA’s Precision Time Protocol (PTP) grandmaster clocks and GNSS receivers provide sub-microsecond accuracy as well as an unprecedented level of robustness and scale. What’s more, the technology’s flexibility and operational simplicity enables a distributed timing architecture with synchronization at the edge of the mobile backhaul network and helps YTL Communications smoothly transitions its legacy infrastructure.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191126005120/en/
The OSA 5410 and OSA 5420 Series is helping YTL Communications to roll out nationwide LTE-Advanced services (Photo: Business Wire)
“ADVA’s Oscilloquartz timing technology has been fundamental to our highly successful 4G rollout. By utilizing the OSA 5410 and 5420 Series to deploy a distributed synchronization architecture, we've been able to provide 4G LTE and 4G broadband services across Malaysia with the nation’s only all-4G network,” said Wing K Lee, CEO, YTL Communications. “We have a strong belief in harnessing the most advanced technology available to provide wider coverage, better quality and more affordable high-speed internet access for the benefit of our customers. Oscilloquartz’s compact and versatile products played an important role in making this a reality. Being able to rapidly and cost-effectively synchronize small cells empowers us to densify our network and deliver coverage in underserved areas.”
YTL Communications’ new synchronization network is built on the OSA 5410 and OSA 5420 Series, a family of cost-effective, mid-scale synchronization distribution and assurance devices. Following a toolbox approach, this technology can be utilized in a variety of network timing applications, including IEEE 1588v2 grandmaster, boundary clock, slave clock and assisted partial timing support. Engineered for deployment in a wide range of locations, the OSA 5410 and 5420 range enables YTL Communications to efficiently distribute synchronization from the network edge. Integrated Syncjack™ technology, which continually monitors synchronization performance while in service, enhances the robustness of the solution. ADVA’s Malaysian partner Preciso Technology Sdn Bhd also played a key role from conducting PoC trials to supporting the installation.
“YTL Communications understand that the only way to keep pace with customer demand is by leveraging the latest innovation. With our highly scalable, ultra-precise timing solution, it now has the power to bring 4G LTE and broadband to every corner of Malaysia and offer better quality SLAs to its enterprise clients,” commented Anil Kumar Reddy, senior director, business development, APAC, Oscilloquartz. “What makes our technology ideal for this project is its small footprint and flexibility. Our OSA 5410 and 5420 Series remove much of the cost and complexity of small cell deployment, giving YTL Communications the freedom to upgrade synchronization in the parts of the access network that need it. By working closely with YTL Communications’ team and our partner Preciso Technology Sdn BhdD, we’ve made sure that the transition has been extremely smooth and very successful.”
“As a key distributor of ADVA’s Oscilloquartz solutions in Malaysia, we know all about the value of highly accurate and reliable timing in mission-critical networks. When you’re dealing with precise synchronization, there’s simply no room for error. That's why we've worked closely with YTL Communications every step of the way to ensure that this solution delivers everything it promises and supports the mass rollout of 4G across the country,” said C S Chong, senior manager, Preciso Technology Sdn Bhd. “The OSA 5410 and 5420 range provides next-generation phase and frequency synchronization together with legacy frequency synchronization. This supports a smooth and cost-effective migration from legacy timing to a network that meets the stringent accuracy and reliability requirements of LTE-A, enabling YTL Communications to maximize the value of its existing investments.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we're building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com.
About Oscilloquartz
Oscilloquartz is a pioneer in time and frequency synchronization. We design, manufacture and deploy end-to- end synchronization systems that ensure the delivery and assurance of highly precise timing information over next-generation packet and legacy networks. As an ADVA company, we're creating new opportunities for tomorrow's networks. For more information, please visit us at www.oscilloquartz.com.
About YTL Communications
YTL Communications Sdn Bhd (793634-V), is a global frontrunner in 4G Internet and operates a robust “YES" 4G network in Malaysia with nationwide population coverage across the country. YES is the 1st and only PURE 100% 4G Mobile Operator in Malaysia. YES has been the first in Malaysia to offer voice-over-LTE (VoLTE) service for high definition, crystal clear calls winning innovation awards for its services annually. YES has been recognised by the Broadband InfoVision Awards under the ‘Best New Service’ category in 2011 and ‘Best Broadband Cloud’ category in 2013, Frost & Sullivan’s ‘Most Innovative Service Provider of the Year 2012’ and ‘Most Promising Telecom Service Provider of the Year 2013’, Telecoms.com’s ‘Best Enterprise Cloud Offering’ and Telecom Asia’s ‘Most Innovative Partnership Strategy’ in 2014, and Telecom Asia’s ‘Most Innovative Voice Service’ for its VoLTE. In 2017, YES was acknowledged by OpenSignal for providing the best overall download speed and best LTE signal availability. YES was awarded the best LTE signal availability and overall video experience by OpenSignal in 2018. In 2019, YES has successfully emerged as the second country in the world and the first in Asia to deploy Terragraph and as of July 2019, has deployed the world’s largest Terragraph network in the world in Georgetown, Penang. YES is the first to introduce twin innovations in not just gigabit wireless mesh network offering free public wifi with the fastest public Wi-fi in the world via Terragraph but also the first to introduce GiGa Wire which modernises existing copper building infrastructures to deliver fiber-like speed. For more information about YES mobile and broadband plans, kindly visit www.yes.my.
Published by:
ADVA Optical Networking SE, Munich, Germany
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191126005120/en/
Contact information
For ADVA press:
Gareth Spence
t +44 1904 699 358
public-relations@adva.com
For ADVA investors:
Stephan Rettenberger
t +49 89 890 665 854
investor-relations@adva.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
